SuperworthRenovoRx market cap RNXT
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $58.2M
- Highest close in our data
- $107.9M
- Sep 2026
RenovoRx is worth $58.2M at the close on Oct 23, 2026, at $1.29 a share.
That is up 35% over the last year and down 1% over five years.
Its highest close in our data was $107.9M in Sep 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $58.2M | $29M | $107.9M | +86% |
| 2025 | $31.3M | $23M | $51.2M | +0% |
| 2024 | $31.2M | $11.2M | $33.6M | +27% |
| 2023 | $24.5M | $6.4M | $47.3M | +15% |
| 2022 | $21.4M | $15.1M | $36.2M | −50% |
| 2021 | $43.1M | $43.1M | $58.7M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest RenovoRx's size, closest first, today.
| Company | Market cap |
|---|---|
| RNXTRenovoRx | $58.2M |
| APTAlpha Pro Tech | $56.7M |
| NEPHNephros | $38.3M |
| KEQUKewaunee Scientific | $94.9M |
| PDEXPro DEX | $199.3M |
| UTMDUtah Medical Products | $236.3M |
| INFUInfuSystem | $277.6M |
| EMBCEmbecta | $380.2M |
| TCMDTactile Systems Technology | $535.5M |
| MDXGMimedx | $569.9M |
| Peer median | $236.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on RenovoRx
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.